0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Distribution of extracellular fluid over the intra- and extravascular space in hypertensive patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The time course of hemodynamic responses to long-standing sodium overload was studied in humans. The study involved six patients who became hypertensive on exposure to excessive mineralocorticoid activity. Arterial pressure, cardiac output, and body fluid volumes were measured with noninvasive methods at weekly intervals for at least 6 weeks and at longer intervals for periods up to 2 years. Extracellular fluid volume was expanded by approximately 20%, and arterial blood pressure rose by 20-40%. Initially, cardiac output was the dominant factor for the pressure rise. But in a later stage the pressure remained high or rose even further, although cardiac output and body fluid volumes fell toward normal. In some cases, particularly in young subjects, it took weeks or months before the total peripheral resistance began to rise, and there was no quantitative relationship between the initial rise in cardiac output and the subsequent rise in resistance. These findings argue against a direct cause-and-effect relation between flow and resistance changes. Preferential expansion of the intravascular compartment was associated with high cardiac output, whereas preferential expansion of the interstitial fluid compartment was associated with high resistance. Thus, the hemodynamic pattern of sodium-induced hypertension seems somehow related to the distribution of extracellular fluid over the intra- and extravascular compartments.

          Related collections

          Author and article information

          Journal
          J Cardiovasc Pharmacol
          Journal of cardiovascular pharmacology
          Ovid Technologies (Wolters Kluwer Health)
          0160-2446
          0160-2446
          1984
          : 6 Suppl 1
          Article
          10.1097/00005344-198400061-00024
          6204133
          12811487-8761-4046-b1f7-5d74679e3673
          History

          Comments

          Comment on this article